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Curiosity first, applications later
Tebello Nyokong speaks to Robert Berold and Janice Limson about her
career as a chemist
TEBELLO NYOKONG, WHO HOLDS Aresearch chair in medicinal chemistryand nanotechnology at Rhodes Uni-
versity, has become the first South African
scientist to win the L’Oréal-UNESCO
award for women in science, in the physical
sciences. Only one laureate is selected
from each of five world regions, and
Nyokong is the 2009 laureate for Africa
and the Arab states. She and the winners
from the other four regions travel to Paris
in March to each accept the award and a
generous prize of close to R1 million.
Nyokong researches the group of
highly coloured compounds called
phthalocyanines which are related to
porphyrins—the dye used in blue jeans is
porphyrin-based, as is haemoglobin,
which gives the red colour to blood. These
compounds have widespread application
as catalysts of chemical and biological
reactions, and have been used as potent
therapies for cancer, as highly sensitive
sensors for detecting pathogens, and in
the cleaning of polluted water. ‘I fell in
love with phthalocyanines,’ she says.
‘They are well behaved, stable, and very
colourful—they are beautiful molecules.
For my Ph.D. I was trying to investigate
whether we could make them water
soluble.’
At that stage there was no thought of
applications: ‘But you know, most research
that goes anywhere is not based on appli-
cations. Curiosity-driven research is how
most discoveries are made. The applica-
tions come later.’
By altering the chemical structure of
phthalocyanines—by changing their
metal centres, adding substituents, or
coupling them with enzymes or nano-
particles such as quantum dots—it
becomes possible to finely tune and
manipulate their properties. The research
by Nyokong and her team into early
warning systems for diseases and environ-
mental toxins has resulted in the develop-
ment of several sensors, including the
most sensitive detection system yet devel-
oped for the neurotransmitter nitric oxide.
One application is in combating cancer,
and here Nyokong’s research takes a
three-tiered approach. The first tier, sensor
research, aims to detect and target cancer-
causing agents before they can do any
harm to the human body. The next tier,
targeting of the specific biological markers
of certain cancers, allows for early diagno-
sis. The third tier is cancer treatment, and
porphyrin-based cancer drugs developed
by Nyokong and her team over several
years are currently undergoing pre-clinical
trials in South Africa.
More recently, with the opportunities
afforded by nanostructured materials,
this research has entered a new phase,
combining the phenomenal physical and
chemical properties of nanostructures
with the catalytic properties of synthetic
porphyrin molecules. This work is an
extension of photodynamic therapy—the
use of specially developed dyes to direct
deadly light onto cancer cells—which is
being researched worldwide as an alter-
native to chemotherapy. In photodynamic
therapy, the dye is injected into the blood-
stream or, for skin cancer, applied directly
to the skin.
When photodynamic therapy is com-
bined with quantum dots, cancer cells can
be killed even more efficiently. Quantum
dots are particles in the nano range which
can be connected to biological molecules,
and so can be directed to targeted biologi-
cal systems for imaging. They can absorb
and re-emit light, so once they are in the
target area, their fluorescence can then be
used to detect tumours.
Nyokong has been one of the very first
proponents of the phthalocyanine-nano-
structure hybrid approach, and one of the
first to extend the field beyond photody-
namic therapy to sensing systems. Her
breakthrough came when she was able to
chemically couple phthalocyanines either
with nanostructures such as multi-walled
and single-walled carbon nanotubes, or
directly to enzymes. ‘Someone from the
National Laser Centre called me at 10 pm
one night—they wanted to come the next
day to discuss the possibility of loaning
me some lasers. I knew this was a great
opportunity, because I needed lasers to
study the molecules we make in the lab.’
Laser technology has since significantly
improved her research in photodynamic
therapy.
Nyokong intends to invest some of her
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prize into seeing these compounds success-
fully through the developmental, trial
and safety testing stages so that they
could become available on the market in
the years to come: ‘All the trials take
forever—there are so many restrictions
and conditions. Someone else can do that.
But we’ve found one drug that is really
going to be a big one. We’ve tested it on
cells and it’s brilliant. We are still doing
more trials before we patent it, but we re-
ally think it’s going to be a world-class
South African drug.’
Another branch of Nyokong’s research
is photosensitised oxidation for pollution
control. Photochemical destruction of
certain pollutants, such as chlorinated
phenols and other pesticides, is commonly
done with ultraviolet light. However, the
products of photodegradation after such
ultraviolet treatment can be more toxic
than the parent compounds. A possible
alternative is photosensitised oxidation.
Nyokong is investigating the use of
phthalocyanines as photosensitisers to
transform chlorinated phenols and other
pollutants into less harmful products.
Nyokong’s own story speaks eloquently
of her tremendous commitment and pas-
sion for science. She was raised in Sharpe-
ville, but her family left for Lesotho soon
after the infamous 1960 massacre. Her
Pan-Africanist father believed strongly in
education for girls, but at the same time
his three daughters were expected to
contribute by helping out in the family’s
construction business, planting, weeding
and harvesting the extensive vegetable
garden, and cleaning the house.
Tebello only started school when she
was eight years old. ‘I was staying with
my paternal grandmother in the Free
State. In those days you were not permit-
ted to enter primary school until you
could reach over your head and touch
your opposite ear, using your hand. I
could only do this when I was eight years
old. Having a short arm was not good for
one’s intellectual development!’ She went
on to school in Lesotho, and remembers
fondly the devotion and discipline of her
(mostly female) teachers. It was a poor
school, with parents and churches having
to build classrooms, and some classes held
under a tree. She saw that with dedicated
teachers ‘one can learn even in very
difficult situations. Yes it would be nice to
have good classrooms, but if they are not
there, learning can go on! We were even
very proud of our classroom under the
tree.’
She excelled at science, but a career in
chemistry was not her first choice. ‘To be
honest I did not even know what jobs one
could get as a chemistry graduate. Like
many young people, I wanted to be a
doctor.’ This ambition had to be shelved
because her father became too ill for her
to take up offers of a dentistry or medical
scholarship abroad. So she decided to
study chemistry in Lesotho and become
a high school teacher. Then she won a
postgraduate scholarship in Canada. ‘By
that time I loved chemistry fully, and I
began to see that even though doctors
cure patients, it is chemists that develop
the medicines. Being a doctor was no
longer so important to me.’
While still at university, Nyokong
married and had two children. She
admits that being a young mother while
studying for her Ph.D. and working as a
cash-strapped teaching assistant was
‘very difficult’. Nor did these difficulties
end when her doctorate was completed.
Research was a lonely road. ‘I had no one
to talk to among my peers when things
went wrong with my research or even
when I got very excited about my research.
I experienced—and still experience—
academic loneliness.’
Racism and sexism were additional
hurdles when she arrived at Rhodes as a
lecturer in 1992. ‘Clearly Rhodes chemistry
students had never been taught by a black
person, let alone a black woman. There
were some difficulties at the beginning
which I soon overcame. But one had to be
very firm!’ By 2001 she was a full professor,
and she has now trained close to 30 M.Sc.
and Ph.D. students. ‘Many of these
children (I can call them children because
I’m older now) come from rural back-
grounds. I think they gravitate towards
me because they also know I’ve come
from there.’ Some have gone on to become
lecturers in chemistry, some have emi-
grated, and some are in industry. ‘I get
tired, though, when I see how many
graduates are money-driven. You should
just work for what you are paid for. It’s all
about commitment.’
Nyokong now heads the new Nano-
technology Innovation Centre for medical
sensors: the biggest single research invest-
ment in the history of Rhodes. Linked to
other nanotechnology centres in the
country, it is designed to bridge the
gap between research and the market.
Developing skills and human resource
capacity in nanotechnology in South
Africa is the centre’s top priority, and
it will conduct both fundamental and
applied research towards the develop-
ment of sensors for early detection of
disease. The centre will investigate new
approaches in molecular immobilisation,
using metal- and carbon-based nano-
particles and nanotubes. It will develop
sensors for the rapid detection of medi-
cally important molecules (such as amino
acids, thiols, neurotransmitters), and
sensors for monitoring biological toxins.
Peter Clayton, deputy vice-chancellor
for research at Rhodes says, ‘What Tebello
Nyokong has achieved is quite staggering.
She literally oozes passion for science—
doing it, teaching it, promoting it, financ-
ing it, and applying it.’
Robert Berold is a writer based in Grahams-
town.
Janice Limson is a senior lecturer in biotech-
nology at Rhodes University.
